More recently, it has been demonstrated that polymorphisms in the gene (TNFSF15) were associated with an increased risk in IBD and that reducing the expression of this gene on monocytes and macrophage is associated with increased susceptibility [58]. This evidence concerns the gene TNFSF15 and irritable bowel syndrome.